NKL homeobox gene activities in B-cell development and lymphomas

Area of Science:

• Molecular Biology
• Developmental Biology
• Cancer Biology

Background:

• Homeobox genes are critical transcription factors regulating development and cell differentiation.
• NKL homeobox genes are implicated in T-cell leukemogenesis due to deregulation in T-cell progenitors.
• Previous work characterized NKL homeobox gene expression in early hematopoiesis and T-cell development.

Purpose of the Study:

• To investigate NKL homeobox gene activity during normal B-cell development.
• To extend the understanding of the NKL-code to the B-cell lymphoid lineage.
• To identify NKL homeobox gene alterations in B-cell malignancies.

Main Methods:

• Analysis of public expression profiling datasets for NKL homeobox gene activity in B-cell subsets.
• Examination of NKL homeobox gene expression in various B-cell malignancies and cell lines.
• Promoter studies and signaling pathway analysis to elucidate regulatory mechanisms of NKX6-3.
• Identification of regulatory gene networks involving NKL homeobox genes in B-cell progenitors.

Main Results:

• HHEX and NKX6-3 were the only differentially active NKL homeobox genes in normal B-cell subsets.
• Aberrant overexpression and ectopic activation of several NKL homeobox genes were observed in B-cell malignancies.
• NKX6-3 showed enhanced activity in patient subsets of follicular lymphoma, mantle cell lymphoma, and diffuse large B-cell lymphoma (DLBCL).
• MYB and PAX5 transcription factors, along with aberrant BMP7/SMAD1 signaling and AUTS2/PCGF5, were found to activate NKX6-3.
• A regulatory gene network involving HHEX, HLX, MSX1, and NKX6-3 was identified in B-cell progenitors.

Conclusions:

• An NKL-code essential for normal B-cell development has been identified.
• Violation of this NKL-code through aberrant gene activity may drive B-cell differentiation defects and malignant transformation.
• These findings provide insights into the molecular mechanisms underlying B-cell malignancies.